Matrix Effectors and Cancer
- PMID: 35008364
- PMCID: PMC8750795
- DOI: 10.3390/cancers14010200
Matrix Effectors and Cancer
Abstract
Extracellular matrices (ECMs) are highly dynamic three-dimensional structural meshworks composed of macromolecules, such as proteoglycans/glycosaminoglycans (PGs/GAGs), collagens, laminins, elastin, (glyco)proteins, and matrix-degrading enzymes, such as proteases and glycosidases [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Karamanos N.K., Piperigkou Z., Theocharis A.D., Watanabe H., Franchi M., Baud S., Brezillon S., Gotte M., Passi A., Vigetti D., et al. Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics. Chem. Rev. 2018;118:9152–9232. doi: 10.1021/acs.chemrev.8b00354. - DOI - PubMed
-
- Silva C.F.S., Motta J.M., Teixeira F., Gomes A.M., Vilanova E., Kozlowski E.O., Borsig L., Pavao M.S.G. Non-anticoagulant heparan sulfate from the ascidian phallusia nigra prevents colon carcinoma metastasis in mice by disrupting platelet-tumor cell interaction. Cancers. 2020;12:1353. doi: 10.3390/cancers12061353. - DOI - PMC - PubMed
-
- Nassar E., Hassan N., El-Ghonaimy E.A., Hassan H., Abdullah M.S., Rottke T.V., Kiesel L., Greve B., Ibrahim S.A., Gotte M. Syndecan-1 promotes angiogenesis in triple-negative breast cancer through the prognostically relevant tissue factor pathway and additional angiogenic routes. Cancers. 2021;13:2318. doi: 10.3390/cancers13102318. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
